Medical Specialties Commons^™

Oncology Referral To Chemotherapy Initiation: Improving Timely Access To Care In Infusion Clinic, Kathy A. Keener

St. Joseph Hospital, Orange, CA. Evidence Based Practice Conference

No abstract provided.

From Imaging To Treatment: Collaboration Optimizes Thoracic Oncology Care, Lauri Ledbeter, Kim Ward, Jana Jensen, Rebekah Hart

2022 Providence Nurse Research Conference

References

Cone, EB., Marchese, M., & Paciotti, M., Nguyen, D., Nabi, J., Cole, A., Molina, G., Molina, R., Minami, C., Mucci, L., Kibel, A. Trinha, Q. (2020). Assessment of time-to-treatment initiation and survival in a cohort of patients with common cancers. JAMA Network Open, 3(12), e2030072. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2774101

Global Cancer Observatory. (2020, December). Cancer Today: Lung. World Health Organization: International Agency for Research on Cancer. https://gco.iarc.fr/today/data/factsheets/cancers/15-Lung-fact-sheet.pdf

Hall, H., Tocock, A., Burdett, S., Fisher, D., Ricketts, W., Robson, J., Round, T., Gorolay, S., MacArthur, E., Chung, D., Janes, S., Peake, M., & Navani, N.(2021). Association between time-to-treatment and outcomes …

Observed Concordance Of Prostate Lesions On Mri With Mri/Ultrasound Fusion Biopsy Results, Kelcie Foshag, Scott King, Chance Brock, Abigail Cone

View All Washington/Montana GME

Presented at the 2022 Virtual Northwest Medical Research Symposium

Splenic Vein Aneurysm: Case Report Of An Exceedingly Rare Condition, Dave Riesberg

View All Washington/Montana GME

Presented at the 2022 Virtual Northwest Medical Research Symposium

Why So Shocky?? A Case Of Refractory Shock, Brittney Ward, Cicily Hummer, Joseph Bell

View All Washington/Montana GME

Presented at the 2022 Virtual Northwest Medical Research Symposium

Malignant Myopericytoma Of The Right Foot: A Case Report, Ryan Glendenning

View All Washington/Montana GME

Presented at the 2022 Virtual Northwest Medical Research Symposium

Risk Of Secondary Malignancies In Ovarian Cancer Survivors: 54,305 Patients Analyzed With 40 Years Of Follow-Up, A C. Casper, M W. Parsons, J Chipman, L M. Burt Jr, G Suneja, K A. Maurer, D K. Gaffney

View All Washington/Montana GME

Presented at the 2022 Virtual Northwest Medical Research Symposium

Psychometric Characteristics And Validity Of The Promis Cancer Function Brief 3d Profile, Sean R. Smith, Mary Vargo, David S Zucker, Samman Shahpar, Lynn Gerber, Maryanne Henderson, Gina Jay, Minji Lee, Andrea Cheville

All Podium Presentations

Purpose: To develop an item response theory (IRT)-calibrated patient-reported outcome measure (PRO) that assesses cancer patient physical function, fatigue and social participation.

Problem Statement: The subspecialty of cancer rehabilitation medicine (CRM) has to date lacked a psychometrically validated patient-reported outcome measure that assesses patients’ physical function, fatigue, and social participation. A significant proportion of the 16.9 million US cancer survivors will experience, or have already experienced, impairments that compromise function, a predictable consequence of their disease and treatment. While each disease site and line of treatment may be associated with unique impairments, there are some that cut across several cancers …

Factors Impacting Genomic Testing Rates Among Epithelial Ovarian Cancer Patients Across A Large Community-Based Healthcare System, Nicole M. Kretzer, Christopher J. Darus, Nancy Biery, Roshanthi Weerasinghe, Grace Li, Ann Vita, Shwetha Pindikuri, Amy S. Parrish, Charles W Drescher, Fernanda B. Musa

All Podium Presentations

Background: Epithelial ovarian cancer (EOC) accounts for the highest mortality of all gynecological cancers. NCCN guidelines recommend germline and somatic testing for all women with invasive EOC. Despite this recommendation, there is a large diversity in the types of testing patients receive even within a single healthcare system. Reported data of genetic testing for epithelial ovarian cancer (EOC) patients is largely based on patients treated at academic medical centers or patients who participate in clinical trials.

Purpose: This study sought to determine the rates of germline and somatic testing for epithelial ovarian cancer patients and identify factors that impact testing …

Patterns Of Genomic Testing For Epithelial Ovarian Cancer Across A Large Community-Based Health Care Network- A Real World Experience, Nicole M. Kretzer, Fernanda B. Musa, Christopher Darus, Nancy Biery, Roshanthi Weerasinghe, Grace Li, Ann Vita, Shwetha Pindikuri, Amy S. Parrish, Charles W Drescher

All Podium Presentations

Background: NCCN guidelines recommend germline and somatic tumor testing for all women with invasive epithelial ovarian cancer (EOC). Despite this recommendation, testing rates remain low and an optimal strategy to achieve the recommended testing has not been defined.

Purpose: We elected to review the patterns of germline and somatic tumor testing for patients with EOC across a large health care network to identify barriers to testing.

Methods: Clinical, pathologic, demographic and genomic testing (GT) information including involvement of a genetic counselor, specific test(s) ordered, test vendor, test turn-around time, and test results were obtained from the diverse dataset within the …

Psychometric Characteristics And Validity Of The Promis Cancer Function Brief 3d Profile, Sean R. Smith, Mary Vargo, David S Zucker, Samman Shahpar, Lynn Gerber, Maryanne Henderson, Gina Jay, Minji Lee, Andrea Cheville

All Poster Presentations

Purpose: To develop an item response theory (IRT)-calibrated patient-reported outcome measure (PRO) that assesses cancer patient physical function, fatigue and social participation.

Problem Statement: The subspecialty of cancer rehabilitation medicine (CRM) has to date lacked a psychometrically validated patient-reported outcome measure that assesses patients’ physical function, fatigue, and social participation. A significant proportion of the 16.9 million US cancer survivors will experience, or have already experienced, impairments that compromise function, a predictable consequence of their disease and treatment. While each disease site and line of treatment may be associated with unique impairments, there are some that cut across several cancers …

Frequency Of Homologous Recombination Deficiency In A Large Community-Based Cohort Of Epithelial Ovarian Cancer Cases, Nicole M. Kretzer, Fernanda B. Musa, Christopher Darus, Nancy Biery, Roshanthi Weerasinghe, Grace Li, Ann Vita, Shwetha Pindikuri, Amy S. Parrish, Charles W Drescher

All Podium Presentations

Purpose/Background: Homologous recombination deficiency (HRD) is a useful predictor of treatment response in patients with epithelial ovarian cancer (EOC). Reported data on the frequency of HRD in EOC is largely based on analysis of patients treated at academic medical centers or who participated in clinical trials. We sought to characterize the frequency of HRD based on mutations in homologous recombination repair (HRR) genes, genomic instability (GI) and loss of heterozygosity (LOH) scores in a large community-based cohort of EOC patients who received genomic testing in the context of routine clinical care.

Methods: Information including patient demographic, tumor stage and histology …